Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EMA Tells Firms To Evaluate OTCs For Carcinogenic Nitrosamines

Sep 27 2019

• By Tom Gallen

3d render of Europe map Earth globe

Related Content

Apotex First In US To Recall OTC Ranitidine Tablets Due To NDMA Impurity

Sep 26 2019

Ranitidine Recalls Begin In Europe As Regulators Take Action

Sep 18 2019

Contamination In Common OTC Antacid Adds To FDA's API Impurity Concerns

Sep 15 2019

Related Companies

Apotex Inc.

Additional Topics

Europe Drug Review Drug Safety OTC Drugs Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window